Kidney Transplant Surgery Recovery, Weeks 1–2: Inpatient and Early Post-Discharge Recovery
Weeks 1–2 after kidney transplant surgery make up phase 1 of 4 in a typical 12-week recovery: Inpatient and Early Post-Discharge Recovery. Your own surgeon's instructions always come first.
Goals for weeks 1–2
- The single most important indicator of how the transplanted kidney is functioning is the serum creatinine level, which your team will check at least daily during hospitalization and then two to three times per week after discharge. A functioning graft should produce urine almost immediately (a living donor kidney typically produces urine on the operating table; a deceased donor kidney may take hours to days, a condition known as delayed graft function or DGF). In the first 24 to 48 hours, many transplanted kidneys enter a polyuric phase, producing large volumes of dilute urine — sometimes 5 to 10 liters per day. This happens because the new kidney is recovering from preservation injury and has not yet regained the ability to concentrate urine efficiently. During this phase, intravenous fluid replacement is carefully matched to urine output to prevent dehydration or electrolyte disturbances.
- After discharge, you will be asked to monitor and record your urine output, fluid intake, daily weight, and blood pressure. Any significant drop in urine output should be reported to your transplant team promptly. A rising creatinine or falling urine output can signal rejection, obstruction (from the ureteral stent or blood clots), dehydration, or medication toxicity — all of which require urgent evaluation and are treatable when caught early.
- Your immunosuppressive regimen will typically consist of three medications working through different mechanisms to prevent your immune system from attacking the transplanted kidney. The standard triple therapy includes tacrolimus (a calcineurin inhibitor that is the backbone of transplant immunosuppression), mycophenolate mofetil (an antimetabolite that suppresses lymphocyte proliferation), and prednisone (a corticosteroid that broadly dampens the immune response). Some centers use induction therapy with basiliximab or antithymocyte globulin at the time of transplant to provide intense early immunosuppression while oral medications reach therapeutic levels.
- Tacrolimus requires trough level monitoring — a blood draw taken 12 hours after your last dose, before your morning dose. These levels are checked frequently in the first weeks (often with each outpatient visit, two to three times weekly) and guide dose adjustments. The therapeutic window is narrow: too little tacrolimus and you risk rejection; too much and you risk nephrotoxicity (damage to the very kidney you just received), tremor, headache, hypertension, diabetes, and in severe cases, posterior reversible encephalopathy syndrome (PRES). Learning to take tacrolimus consistently — same times each day, on an empty stomach or consistently with food as directed, never missing a dose — is perhaps the single most important thing you will do for your transplanted kidney.
- The consequences of non-adherence cannot be overstated. Even brief lapses in immunosuppression can trigger rejection episodes that cause permanent damage to the graft. Studies consistently show that medication non-adherence is one of the leading causes of late graft loss, particularly in younger patients and adolescents. Build routines, use pill organizers, set alarms, and create redundant systems to ensure you never miss a dose. If you do miss a dose or vomit within an hour of taking medications, contact your transplant team for guidance on whether and when to re-dose.
- Adequate hydration is critical in the early post-transplant period. The transplanted kidney is recovering from ischemia (the period between removal from the donor and reperfusion in the recipient) and is more vulnerable to dehydration-related injury than a native kidney. Your team will set a daily fluid intake target, typically 2 to 3 liters, which should be maintained consistently. Water is ideal; avoid excessive caffeine (mild diuretic effect) and sugary beverages (contribute to post-transplant metabolic syndrome).
- Electrolyte disturbances are common in the early weeks. The polyuric phase can cause significant potassium, magnesium, and phosphate wasting, requiring oral or intravenous supplementation. Conversely, as graft function stabilizes and the polyuric phase resolves, potassium levels may rise — particularly because tacrolimus itself causes potassium retention. Your team will monitor electrolytes closely and adjust supplements and dietary guidance accordingly. If your potassium or phosphorus levels are elevated, you may be asked to follow a temporary low-potassium or low-phosphorus diet until levels normalize.
- Magnesium wasting is a particularly common and persistent problem after kidney transplant, driven by tacrolimus's effect on renal magnesium handling. Many patients require long-term oral magnesium supplementation. Low magnesium can cause muscle cramps, tremor (compounding tacrolimus tremor), and fatigue.
- You are now immunosuppressed, and the level of immunosuppression in the first three months is the highest it will ever be. Your body's ability to fight infections is significantly reduced, and infections that would be trivial in an immunocompetent person can become serious or life-threatening. The major prophylactic medications you will take include valganciclovir for cytomegalovirus (CMV) prevention — CMV is the most common opportunistic viral infection after transplant and can directly damage the graft — trimethoprim-sulfamethoxazole (TMP-SMX or Bactrim) for Pneumocystis jirovecii pneumonia (PCP) prevention, and an antifungal agent (nystatin or fluconazole) for the first one to three months.
- Beyond medication prophylaxis, behavioral measures are essential. Frequent and thorough hand washing is the single most effective infection prevention measure. Avoid close contact with people who are actively ill. Avoid crowds and enclosed public spaces when possible in the first three months. Practice food safety rigorously: no raw or undercooked meat, fish, or eggs; no unpasteurized dairy products; wash all produce thoroughly; avoid buffets and food of uncertain preparation. Avoid gardening without gloves, contact with animal feces (especially cat litter, which can transmit toxoplasmosis), and stagnant water. These precautions are most stringent in the first three to six months and are relaxed gradually as immunosuppression is reduced, though a baseline level of vigilance remains lifelong.
- The incision is typically a curved line in the lower abdomen (right or left iliac fossa), approximately 15 to 20 centimeters long. It is closed in layers with deep absorbable sutures and skin closure with staples, sutures, or adhesive strips. Wound care is straightforward: keep the incision clean and dry, inspect it daily for signs of infection (increasing redness, warmth, swelling, or drainage), and avoid submerging it in water until fully healed (typically 3 to 4 weeks). A Foley catheter is placed during surgery to monitor urine output and protect the ureteral anastomosis; it is typically removed on post-operative day 3 to 5. After catheter removal, some patients experience temporary urinary frequency or mild dysuria that resolves over days.
- The ureteral stent placed at surgery is not visible externally and does not cause symptoms in most patients, though some experience bladder irritation, urgency, or mild flank discomfort. The stent is removed by cystoscopy (a brief outpatient procedure) at 4 to 6 weeks post-transplant. Until stent removal, some patients notice blood-tinged urine with physical activity, which is generally benign but should be reported if heavy or persistent.
- Fluid intake and urine output (volume estimation)
- Daily weight (same time, same clothing, same scale)
- Blood pressure and heart rate
- Temperature (report any fever above 38.0C)
- Medication adherence confirmation
- Wound inspection (photo for check-in)
- Symptoms: pain, swelling, urinary changes, gastrointestinal issues
- Blood glucose (if monitoring for NODAT)
- Mood and energy level
What to avoid in weeks 1–2
- No lifting heavier than 5 kg for the first 6 weeks (protects the iliac fossa incision and graft position)
- No driving until transplant team clearance (typically 4-6 weeks)
- No submersion of wound in water until fully healed
- No contact sports or activities with abdominal/pelvic trauma risk (the transplanted kidney sits superficially and is vulnerable)
- Strict medication adherence — never miss a dose, never adjust without team guidance
- Infection precautions as outlined above
- No live vaccines (lifelong)
- No NSAIDs (nephrotoxic; acetaminophen only for pain relief)
- No grapefruit or grapefruit juice (alters tacrolimus metabolism significantly)
- No herbal supplements or over-the-counter medications without transplant team approval (St. John's Wort, for example, dramatically reduces tacrolimus levels and can trigger rejection)
Call your care team if, during weeks 1–2:
- Sudden decrease or cessation of urine output (graft thrombosis or obstruction until proven otherwise)
- Fever above 38.5C with rigors or hemodynamic changes (sepsis in immunosuppressed patient)
- Severe pain or swelling over the graft site with firmness (hemorrhage or graft rupture)
- Gross hematuria that is heavy, clot-forming, or accompanied by pain
- Signs of pulmonary embolism: sudden dyspnea, pleuritic chest pain, oxygen desaturation
- Signs of stroke: new focal neurologic deficit, speech difficulty, facial asymmetry
- Wound dehiscence with exposed tissue or fascial separation
- Severe headache with visual changes (hypertensive emergency, PRES syndrome with tacrolimus)
- Seizure (tacrolimus toxicity or PRES until proven otherwise)
Weeks 3–6: Stabilization and Graft Optimization →
See the whole recovery timeline →
Follow weeks 1–2 in Surgily
Surgily shows each day's exercises for this phase, lets you log how you feel in 30 seconds and share it with your care team, and tells you clearly when to get help.
Get my recovery plan →